A detailed history of Ar Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ar Asset Management Inc holds 59,774 shares of BMY stock, worth $3.45 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
59,774
Previous 59,774 -0.0%
Holding current value
$3.45 Million
Previous $2.48 Million 24.62%
% of portfolio
0.69%
Previous 0.6%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $28,669 - $31,832
-450 Reduced 0.75%
59,774 $3.82 Million
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $39 - $23,052
300 Added 0.5%
60,224 $4.28 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $461,920 - $523,440
-8,000 Reduced 11.78%
59,924 $3.72 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $371,200 - $539,440
8,000 Added 13.35%
67,924 $3.79 Million
Q2 2017

Aug 07, 2017

BUY
N/A
59,924
59,924 $3.34 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ar Asset Management Inc Portfolio

Follow Ar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ar Asset Management Inc with notifications on news.